)--Linking the technological frontier, serving business innovationAugust 1 News: ThirdEye partners with portable ultrasound manufacturer Dolphin Medical Imaging to promote the application of AR glasses in medical scenarios. Initially, the two companies used the ThirdEye X2 AR glasses to help clinicians locate blood vessels for urinary catheterization. Currently, they have integrated the X2 with mobile devices to project real-time data from Dolphin’s ultrasound system directly into physicians’ field of view.
Dolphin’s Chief Medical Officer, Mel Harris, stated: “In the past, physicians could view data on tablets; however, when treating emergency patients, they need this information to be immediately accessible. Through our partnership with ThirdEye, we have simplified ultrasound imaging technology, reducing both cost and device size, thereby enabling physicians to deliver an optimized healthcare experience for patients. Looking ahead, we will continue to expand this collaboration, deploying AR glasses in pre-hospital care, emergency inpatient services, and critical care settings.”
It is understood that, compared with other AR headset manufacturers on the market, ThirdEye’s advantage lies in the portability and low cost of its AR glasses. Taking the X2 model as an example, it features a 42° field of view, 720p resolution per eye, and a 60fps refresh rate. Its volume is approximately half that of the HoloLens, and it is more affordable, priced at $1,950. Currently, ThirdEye has collaborated with global partners to develop over 1,000 applications for use in a wide variety of scenarios.
ThirdEye CEO Nick Cherukuri stated that the AR glasses developed by ThirdEye are comfortable enough to be worn continuously for several hours, support various lighting conditions, and are priced affordably for large-scale deployment. In addition to ultrasound applications, Cherukuri is optimistic about using AR to treat patients with visual impairments and to facilitate remote collaboration among physicians. This article was translated by Qingting.com from:MedCityNews